Prestige Consumer Healthcare Inc. (PBH) P/E Ratio History
Historical price-to-earnings valuation from 2006 to 2026
Loading P/E history...
PBH Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Prestige Consumer Healthcare Inc. (PBH) trades at a price-to-earnings ratio of 12.7x, with a stock price of $54.59 and trailing twelve-month earnings per share of $3.88.
The current P/E is 16% below its 5-year average of 15.2x. Over the past five years, PBH's P/E has ranged from a low of 10.6x to a high of 20.0x, placing the current valuation at the 20th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, PBH trades at a 43% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
The PEG ratio of 1.40 (P/E divided by 3% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, PBH trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PBH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PBH P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 20.4 | 1.57 | -6% | |
| $22B | 31.1 | - | +27% | |
| $1B | 5.6Lowest | 0.15Best | +538%Best | |
| $34B | 23.3 | - | +41% | |
| $41B | 19.1 | 2.26 | +13% | |
| $7B | 50.3 | - | -4% | |
| $973M | 33.3 | - | +104% | |
| $897M | 41.5 | - | -23% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
PBH Historical P/E Data (2006–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | Wed Dec 31 2025 00:00:00 GM | $61.69 | $3.78 | 16.3x | -15% |
| FY2026 Q2 | $62.40 | $4.03 | 15.5x | -19% | |
| FY2026 Q1 | Mon Jun 30 2025 00:00:00 GM | $79.85 | $4.26 | 18.7x | -2% |
| FY2025 Q4 | Mon Mar 31 2025 00:00:00 GM | $85.97 | $4.29 | 20.0x | +5% |
| FY2025 Q3 | $78.09 | $4.27 | 18.3x | -5% | |
| FY2025 Q2 | Mon Sep 30 2024 00:00:00 GM | $72.10 | $4.11 | 17.5x | -8% |
| FY2025 Q1 | Sun Jun 30 2024 00:00:00 GM | $68.85 | $4.09 | 16.8x | -12% |
| FY2024 Q4 | Sun Mar 31 2024 00:00:00 GM | $72.56 | $4.17 | 17.4x | -9% |
| FY2023 Q3 | Sat Dec 31 2022 00:00:00 GM | $62.60 | $4.17 | 15.0x | -22% |
| FY2023 Q2 | Fri Sep 30 2022 00:00:00 GM | $49.83 | $4.12 | 12.1x | -37% |
| FY2023 Q1 | $58.80 | $3.99 | 14.7x | -23% | |
| FY2022 Q4 | $52.94 | $4.04 | 13.1x | -32% |
Average P/E for displayed period: 19.2x
See PBH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PBH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PBH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPBH — Frequently Asked Questions
Quick answers to the most common questions about buying PBH stock.
Is PBH stock overvalued or undervalued?
PBH trades at 12.7x P/E, near its 5-year average of 15.2x. The 20th percentile ranking places valuation within normal historical bounds.
How does PBH's valuation compare to peers?
Prestige Consumer Healthcare Inc. P/E of 12.7x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is PBH's PEG ratio?
PBH PEG ratio is 1.40. Between 1-2 suggests valuation aligns with growth. Historical P/E data spans 2006-2026.